Nocturia: The major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO)

European Urology, Supplements

Volumn 3, Issue 6, 2005, Pages 8-16

  Abrams, Paul ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

5 reductase inhibitors; Benign prostatic obstruction; Bothersomeness; Decreased bladder capacity; Lower urinary tract symptoms; Nocturia; Nocturnal polyuria; Quality of life; 1 adrenoceptor antagonists

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ANTIDIURESIS; BEHAVIOR; BLADDER CAPACITY; CIRCADIAN RHYTHM; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DIURESIS; HORMONE ACTION; HUMAN; IMPAIRED BLADDER EMPTYING; MICTURITION; NOCTURIA; PATIENT SATISFACTION; POLYURIA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SLEEP APNEA SYNDROME; SLEEP PATTERN; SLEEP WAKING CYCLE; URINARY EXCRETION; URINARY TRACT OBSTRUCTION; WELLBEING;

EID: 14844347966     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(05)80002-8     Document Type: Article

References (69)

1. Chasens E., and Umlauf M.G. Nocturia: a problem that disrupts sleep and predicts obstructive sleep apnea Geriatr Nurs 24 2003 76 81
2. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., van Kerrebroeck P., Victor A., and Wein A. The standardisation of terminology in lower urinary tract function: report from the standardisation subcommittee of the International Continence Society Urology 61 2003 37 49
3. Van Kerrebroeck P., Abrams P., Chaikin D., Donovan J., Fonda D., Jackson S., Jennum P., Johnson T., Lose G.R., Mattiason A., Robertson G.L., and Weiss J. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society BJU Int 90 Suppl 3 2002 11 15
4. Van Dijk L., Kooij D.G., and Schellevis F.G. Nocturia in the Dutch adult population BJU Int 90 2002 644 648
5. Schatzl G., Temml C., Schmidbauer J., Dolezal B., Haidinger G., and Madersbacher S. Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project Urology 56 2000 71 75
6. Fourcade R.-O., Chauvin I., Gaudin A.-F., Mazzetta C., and Boyle P. Prévalence de la nycturie chez los adultes auxerrois: volet français de l'étude UrEpik Prog Urol 11 2001 1251 1258
7. Jolleys T.V., Donovan J.L., Nanchahal K., Peters T.J., and Abrams P. Urinary symptoms in the community: how bothersome are they? Br J Urol 74 1994 551 555
8. Chute C.G., Panser L.A., Girman C.J., Oesterling J.E., Guess H.A., Jacobsen S.J., and Lieber M.M. The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 150 1993 85 89
9. Johnson T.M., Jones K., Williford W.O., Kutner M.H., Issa M.M., and Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial J Urol 170 2003 145 148
10. Reinhardt H.W., and Seeliger E. Toward an integrative concept of control of total body sodium News Physiol Sci 15 2000 319 325
11. Donahue J.L., and Lowenthal D.T. Nocturnal polyuria in the elderly person Am J Med Sci 314 1997 232 238
12. McCann S.M., Gutkowska J., and Antunes-Rodrigues J. Neuroendocrine control of body fluid homeostasis Braz J Med Biol Res 26 2003 165 181
13. Cho Y., Somer B.G., and Amatya A. Natriuretic peptides and their therapeutic potential Heart Dis 1 1999 305 328
14. Carey R.M., and Siragy H.M. Newly recognized compounds of the reninangiotensin system: potential roles in cardiovascular and renal regulation Endocr Rev 24 2003 261 271
15. Chou C.L., Yip K.P., Michea L., Kador K., Ferraris J.D., Wade J.B., and Knepper M.A. Regulation of aquaporin-2 trafficking by vasopressin in the renal collecting duct. Roles of ryanodine-sensitive Cat+ stores and calmodulin J Biol Chem 275 2000 36839 36846
16. Kirkland J.L., Lye M., Levy D.W., and Banerjee A.K. Patterns of urine flow and electrolyte excretion in healthy elderly people Br Med J 287 1983 1665 1667
17. Lye M. Rhythm of life and vicissitudes of old age Lancet 353 1999 1461 1462
18. Asplund R. Nocturia, polyuria and sleep quality in the elderly J Psychosom Res 56 2004 517 525
19. Poulton E.M. Relative nocturnal polyuria as a factor in enuresis Lancet 2 1952 906 907
20. Rittig S., Knudsen U.B., Norgaard J.P., Pedersen E.B., and Djurhuus J.C. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis Am J Physiol 256 1989 F664 F671
21. Neveus T., Hansell P., and Stenberg A. Vasopressin and hypercalciuria in enuresis: a reappraisal BJU Int 90 2002 725 729
22. Ali A., and Snape J. Nocturia in older people: a review of causes, consequences, assessment and management Int J Clin Pract 58 2004 366 373
23. Asplund R. Diuresis pattern, plasma vasopressin and blood pressure in healthy elderly persons with nocturia and nocturnal polyuria Neth J Med 60 2002 276 280
24. Saito M., Kondo A., Kato T., and Yamada Y. Frequency volume charts: comparison of frequency between elderly and adult patients Br J Urol 72 1993 38 41
25. Bankir L., Bardoux P., and Ahloulay M. Vasopressin and diabetes mellitus Nephron 87 2001 8 18
26. Adam P. Evaluation and management of diabetes insipidus Am Fam Phys 55 1997 2146 2154
27. Asplund R. The nocturia polyuria syndrome (NPS) Gen Pharmacol 26 1995 1203 1209
28. Ku J.H., Lim D.J., Byun S.-S., Paick J.-S., and Oh S.-J. Nocturia in patients with lower urinary tract symptoms: association with diurnal voiding patterns BJU Int 93 2004 1005 1008
29. Blanker M.H., Bohnen A.M., Groeneveld F.P.M.J., Bernsen R., Prins A.D., and Bosch J.L.H. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men J Urol 164 2000 1201 1205
30. Bodo G., Gontero P., Casetta G., Alpa M., Brossa G., Russo R., and Tizzani A. Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal Scand J Urol Nephrol 32 1998 320 324
31. Asplund R., Sundberg B., and Bengtsson P. Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose-titration study Br J Urology 82 1998 642 646
32. Hofinan M.A. The human circadian clock and aging Chronobiol Int 17 2000 245 259
33. Miller M. Nocturnal polyuria in older people: pathophysiology and clinical implications J Am Geriatr Sac 48 2000 1321 1329
34. Umlauf M.G., and Chasens E.R. Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis Sleep Med Rev 7 2003 403 411
35. Madersbacher S., Pycha A., Klingler C.H., Mian C., Djavan B., Stulnig T., and Marberger M. Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms Neuxourol Urodyn 18 1999 3 15
36. Price D. Potential mechanisms of action of superselective α1-adrenoceptor antagonists Eur Urol 10 Supp 4 2001 5 11
37. Djavan B. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life Urology 62 Suppl 3A 2003 6 14
38. Homma Y., Yamaguchi T., Kondo Y., Horie S., Takahashi S., and Kitamura T. Significance of nocturia in the International Prostate Symptom Score for benign pros tatic hyperplasia J Urol 167 2002 172 176
39. Yoshimura K., Ohara H., Ichioka K., Terada N., Matsui Y., Terai A., and Arai Y. Nocturia and benign prostatic hyperplasia Urology 61 2003 786 790
40. 5 Andersson K.E. Storage and voiding symptoms: pathophysiologic aspects Urology 62 Suppl 2 2003 3 10
41. Middelkoop H.A.M., Smilde-van den Doel D.A., Neven A.K., Kamphuisen H.A., and Springer C.P. Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep J Gerontol A 51 1996 M108 M115
42. Asplund R, and Åberg H. Health of the elderly with regard to sleep and nocturnal micturition Scand J Prim Health Care 10 1992 98 104
43. Coyne K.S., Zhou Z., Bhattacharyya S.K., Thompson C.L., Dhawan R., and Versi E. The prevalence of nocturia and its effect on health-related quality of sleep in a community sample in the USA BJU Int 92 2003 948 954
44. Asplund R., and Åberg H. Nocturnal micturition, sleep and well-being in women of ages 40-64 years Maturitas 24 1996 73 81
45. Mitropoulos D., Anastasiou I., Giannopoulou C., Nikolopoulos P., Alamanis C., Zervas A., and Dimopoulos C. Symptomatic benign prostatic hyperplasia: impact on partners' quality of life Eur Urol 41 2002 240 245
46. Pollak C.P., Perlick D., Linsner J.P., Wenston J., and Hsieh F. Sleep problems in the community elderly as predictors of death and nursing home placement J Community Health 15 1990 123 135
47. Asplund R., Henriksson S., Johannson S., and Isacsson G. Nocturia and depression BJU Int 93 2004 1253 1256
48. Asplund R. Mortality in the elderly in relation to nocturnal micturition BJU Int 84 1999 297 301
49. Stewart R.E., Moore M.T., May F.E., Marks R.G., and Hale W.E. Nocturia: a risk factor for falls in the elderly J Am Geriatr Soc 40 1992 1217 1220
50. Asplund R. Nocturia: consequences for sleep and daytime activities and associated risks Eur Urol Suppl 3 6 2005 24 32
51. Kobelt G., Borgström F., and Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia BJU Int 91 2003 190 195
52. Peters T.J., Donovan J.L., Kay H.E., Abrams P., de la Rosette J.J.M.C.H., Porru D., Thüroff J.W. International Continence Society "Benign prostatic hyperplasia" study group The International Continence Society "benign prostatic hyperplasia" study: the bothersomeness of urinary symptoms J Urol 157 1997 885 889
53. Sagnier P.-P., MacFarlane G., Teillac P., Botto H., Richard F., and Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community J Urol 153 1995 669 673
54. Scarpa R.M. Lower urinary tract symptoms: what are the implications for the patients Eur Urol 40 Suppl 4 2001 12 20
55. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department ofVeterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia J Urol 150 1993 1696 1700
56. Yoshimura K., Arai Y., Ichioka K., Terada N., Matsuta Y., and Okubo K. Symptom-specific quality of life in patients with benign prostatic hyperplasia Int J Urol 9 2002 485 490
57. Eckhardt M., van Venrooij G.E.P.M., van Melick H.H.E., and Boon T.A. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being J Urol 166 2001 563 568
58. Berges R. Impact of therapy used in clinical practice on lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) disease progression Eur Urol Suppl 2 2003 19 24
59. Lepor H., Williford W.O., Barry M.J., Brawer M.K., Dixon C.M., Gormley G., Haakenson C., Machi M., Narayan P., and Padley R.J. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia N Engl J Med 335 1996 533 539
60. Debruyne F.M.J., Jardin A., Colloi D., Resel L., Witjes W.P., Delauche-Cavallier M.C., McCarthy C., and Geffiaud-Ricouard C. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia Eur Urol 34 1998 169 175
61. Kirby R.S., Roehrbom C., Boyle P., Bartsch G., Jardin A., Cary M.M., Sweeney M., and Grossman E.B. Prospective European Doxazosin and Combination Therapy Study Investigators. Efficacy and tolerability of doxazosin and finasteride, alone or incombination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial Urology 61 2003 119 126
62. Rigatti B., Brausi M., Scarpa R.M., Porru D., Schumacher H., and Rizzi C.A. A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 6 2003 315 323
63. McConnell J.D., Roehrborn C.G., Bautista O.M., Andriole G.L., Dixon C.M., Kusek J.W., Lepor H., McVary K.T., Nyberg L.M., Clarke H.S., Crawford E.D., Diokno A., Foley J.P., Foster H.E., Jacobs S.C., Kaplan S.A., Kreder K.J., Lieber M.M., Lucia M.S., Miller G.J., Menon M., Milam D.F., Ramsdell J.W., Schenkman N.S., Slawin K.M., Smith J.A. Medical Therapy of Prostatic Symptoms (MTOPS) Research Group The longterm effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Eng J Med 349 2003 2387 2398
64. Donovan J.L. Measuring the impact of nocturia on quality of life BJU Int 84 Suppl 1 1999 21 25
65. Van Dijk L., Kooij D.G., Schellevis F.G., Kaptein A.A., Boon T.A., and Wooning M. Nocturia: impact on quality of life in a Dutch adult population BJU Int 93 2004 1001 1004
66. Abraham L., Hareendran A., Mills I.W., Martin M.J., Abrams P., Drake M.J., MacDonagh R.P., and Noble J.G. Development and validation of a qualityof-life measure for men with nocturia Urology 63 2004 481 486
67. Abs 595 Avery K., Hashim H., Gardener N., Abrams P., Donovan J., and Abraham L. Development and psychometric evaluation of the ICIQ nocturia module: the ICIQ-N Neurourol Urodyn 23 2004
68. Stanley N. The physiology of sleep and the impact of ageing Eur Urol Suppl 3 6 2005 17 23
69. Åkerstedt T., and Nilsson P.M. Sleep as a restitution: an introduction J Int Med 254 2003 6 12